Drug-Induced Cognitive Impairment: Drug-Induced Cognitive Impairment: A. Reimers et al.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 4
Results: 11
1
2
Authors' response to Tran et al.'s comment on "The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications": The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population: Y. Belsti et al
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 439, doi. 10.1007/s40264-025-01534-9
- By:
- Publication type:
- Article
3
Comment on: "The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications": Comment on "The Use of Multiple Medications During Pregnancy Among an Ethnically: M.-H. Tran et al
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 437, doi. 10.1007/s40264-025-01532-x
- By:
- Publication type:
- Article
4
Clinical Relatedness and Stability of vigiVec Semantic Vector Representations of Adverse Events and Drugs in Pharmacovigilance: vigiVec Semantic Vector Representations of AEs and Drugs in Pharmacovigilance: N. Erlanson et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 401, doi. 10.1007/s40264-024-01509-2
- By:
- Publication type:
- Article
5
Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review: Methods for ADE Detection in Electronic Health/Medical Records: S. Golder et al.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
6
Use of Reporting Recommendation Intended for Pharmaceutical Risk Minimisation Evaluation Studies (RIMES) Checklist in Risk Minimisation/Mitigation Studies: A Review and Survey: Use and Awareness of RIMES Checklist: S. E. Duckworth et al.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
7
OpenPVSignal Knowledge Graph: Pharmacovigilance Signal Reports in a Computationally Exploitable FAIR Representation: OpenPVSignal Knowledge Graph: Pharmacovigilance Signal Reports: A. Chytas et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 425, doi. 10.1007/s40264-024-01503-8
- By:
- Publication type:
- Article
8
Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study: Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: N. Brusselaers et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 389, doi. 10.1007/s40264-024-01502-9
- By:
- Publication type:
- Article
9
Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study: Adverse Drug Events in Ambulatory Care: J.M. Plasek et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 363, doi. 10.1007/s40264-024-01501-w
- By:
- Publication type:
- Article
10
Prenatal and Early Childhood Exposure to Proton Pump Inhibitors and Antibiotics and the Risk of Childhood Cancer: A Nationwide Population-Based Cohort Study: Microbiome Modulating Drugs and Childhood Cancer Risk: U. Gudnadottir et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 375, doi. 10.1007/s40264-024-01500-x
- By:
- Publication type:
- Article
11
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health: C. Lunghi et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 4, p. 315, doi. 10.1007/s40264-024-01497-3
- By:
- Publication type:
- Article